Minimally invasive quantification of cerebral P2X7R occupancy using dynamic [


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 08 2021
Historique:
received: 06 03 2021
accepted: 29 07 2021
entrez: 10 8 2021
pubmed: 11 8 2021
medline: 12 11 2021
Statut: epublish

Résumé

[

Identifiants

pubmed: 34373571
doi: 10.1038/s41598-021-95715-y
pii: 10.1038/s41598-021-95715-y
pmc: PMC8352986
doi:

Substances chimiques

Fluorine Radioisotopes 0
Ligands 0
P2RX7 protein, human 0
Radiopharmaceuticals 0
Receptors, Purinergic P2X7 0
Fluorine-18 GZ5I74KB8G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16172

Informations de copyright

© 2021. The Author(s).

Références

Mol Imaging Biol. 2019 Oct;21(5):871-878
pubmed: 30632003
EJNMMI Res. 2017 Dec;7(1):31
pubmed: 28374288
EJNMMI Res. 2018 Nov 29;8(1):102
pubmed: 30498919
J Cereb Blood Flow Metab. 2010 Jan;30(1):46-50
pubmed: 19738632
J Cereb Blood Flow Metab. 2011 Oct;31(10):1986-98
pubmed: 21811289
Neurobiol Aging. 2015 Jul;36(7):2304-2318
pubmed: 25983062
J Cereb Blood Flow Metab. 1998 Jul;18(7):716-23
pubmed: 9663501
Dis Model Mech. 2014 Sep;7(9):1101-9
pubmed: 25038061
J Nucl Med. 2017 Mar;58(3):458-465
pubmed: 27765863
Front Pharmacol. 2018 Feb 01;9:30
pubmed: 29449810
J Immunol. 2013 May 15;190(10):5187-95
pubmed: 23589615
Front Neurol. 2018 Jun 29;9:516
pubmed: 30013509
Med Phys. 2015 Nov;42(11):6736-44
pubmed: 26520763
J Nucl Med. 2019 Aug;60(8):1154-1159
pubmed: 30733317
EJNMMI Res. 2013 Dec 27;3(1):84
pubmed: 24369816
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2051-2064
pubmed: 31243495
Tanaffos. 2012;11(2):6-11
pubmed: 25191407
J Nucl Med. 2016 Sep;57(9):1436-41
pubmed: 27199364
Neurosci Biobehav Rev. 2018 Apr;87:192-205
pubmed: 29453990
J Nucl Med. 2020 Apr;61(4):604-607
pubmed: 31562223
Hum Brain Mapp. 2019 Dec 15;40(18):5424-5442
pubmed: 31520513
FASEB J. 2009 Jun;23(6):1893-906
pubmed: 19171786
J Cereb Blood Flow Metab. 1990 Sep;10(5):740-7
pubmed: 2384545
Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):169-78
pubmed: 15129698
Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):379-389
pubmed: 31705174
J Nucl Med. 2019 Jul;60(7):930-936
pubmed: 30655332
Neuropharmacology. 2013 Oct;73:311-9
pubmed: 23770338
J Cereb Blood Flow Metab. 2019 Aug;39(8):1516-1530
pubmed: 29790820
J Nucl Med. 2020 Feb;61(2):276-284
pubmed: 31375567
Front Cell Neurosci. 2015 Jul 08;9:258
pubmed: 26217184
PLoS One. 2015 Apr 07;10(4):e0122920
pubmed: 25849581
J Cereb Blood Flow Metab. 2009 Nov;29(11):1825-35
pubmed: 19584890
PLoS One. 2017 May 17;12(5):e0177785
pubmed: 28545084
Arch Immunol Ther Exp (Warsz). 2010 Apr;58(2):91-6
pubmed: 20143170
Alzheimers Dement (N Y). 2017 Aug 30;3(4):481-486
pubmed: 29124105
J Nucl Med. 2019 May;60(5):683-690
pubmed: 30262518

Auteurs

Nathalie Mertens (N)

Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, University Hospital and KU Leuven, Herestraat 49, 3000, Leuven, Belgium. nathalie.mertens@kuleuven.be.

Mark E Schmidt (ME)

Janssen Research and Development, Beerse, Belgium.

Anja Hijzen (A)

Janssen Research and Development, Beerse, Belgium.

Donatienne Van Weehaeghe (D)

Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, University Hospital and KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Paulien Ravenstijn (P)

Janssen Research and Development, Beerse, Belgium.

Marleen Depre (M)

Center for Clinical Pharmacology, University Hospital and KU Leuven, Leuven, Belgium.

Jan de Hoon (J)

Center for Clinical Pharmacology, University Hospital and KU Leuven, Leuven, Belgium.

Koen Van Laere (K)

Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, University Hospital and KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Michel Koole (M)

Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, University Hospital and KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH